Patel Mahesh V. 4
4 · Lipocine Inc. · Filed Jan 3, 2022
Insider Transaction Report
Form 4
Lipocine Inc.LPCN
Patel Mahesh V.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-03$1.09/sh+287,500$313,375→ 287,500 totalExercise: $1.09From: 2023-01-03Exp: 2032-01-03→ Common Stock (287,500 underlying)
Footnotes (1)
- [F1]Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of January 3, 2023, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years.